Showing results (251-260 of 277) with videos related to
Sort By:
Pageof 28
The New England Journal of Medicine|April 20, 2017
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque PsoriasisKim A Papp, Andrew Blauvelt, Michael Bukhalo, et al.The Journal of Investigative Dermatology|June 29, 2019
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic DermatitisChris Callewaert, Teruaki Nakatsuji, Rob Knight, et al.Human Genetics|October 20, 2005
Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCRCynthia Helms, Nancy L Saccone, Li Cao, et al.Journal of the American Academy of Dermatology|June 17, 2009
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approachBruce Strober, Emily Berger, Jennifer Cather, et al.Journal of the American Academy of Dermatology|June 5, 2019
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled studyMegan H Noe, Marilyn T Wan, Daniel B Shin, et al.International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.Lancet (London, England)|June 15, 2015
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsChristopher E M Griffiths, Kristian Reich, Mark Lebwohl, et al.Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.Plos Genetics|March 29, 2008
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease lociYing Liu, Cynthia Helms, Wilson Liao, et al.The Journal of Allergy and Clinical Immunology|September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitisEmma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.Pageof 28